Literature DB >> 20619394

Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation: a prospective randomized study.

Susumu Eguchi1, Mitsuhisa Takatsuki, Masaaki Hidaka, Akihiko Soyama, Tatsuki Ichikawa, Takashi Kanematsu.   

Abstract

BACKGROUND: Although the effect of synbiotic therapy using prebiotics and probiotics has been reported in hepatobiliary surgery, there are no reports of the effect on elective living-donor liver transplantation (LDLT).
METHODS: Fifty adult patients undergoing LDLT between September 2005 and June 2009 were randomized into a group receiving 2 days of preoperative and 2 weeks of postoperative synbiotic therapy (Bifidobacterium breve, Lactobacillus casei, and galactooligosaccharides [the BLO group]) and a group without synbiotic therapy (the control group). Postoperative infectious complications were recorded as well as fecal microflora before and after LDLT in each group.
RESULTS: Only 1 systemic infection occurred in the BLO group (4%), whereas the control group showed 6 infectious complications (24%), with 3 cases of sepsis and 3 urinary tract infections with Enterococcus spp (P = .033 vs BLO group). No other type of complication showed any difference between the groups.
CONCLUSIONS: Infectious complications after elective LDLT significantly decreased with the perioperative administration of synbiotic therapy.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20619394     DOI: 10.1016/j.amjsurg.2010.02.013

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  24 in total

1.  Impact of perioperative probiotic treatment for surgical site infections in patients with colorectal cancer.

Authors:  Naoya Aisu; Shu Tanimura; Yuichi Yamashita; Kanefumi Yamashita; Kenji Maki; Yoichiro Yoshida; Takamitsu Sasaki; Shinsuke Takeno; Seiichiro Hoshino
Journal:  Exp Ther Med       Date:  2015-07-15       Impact factor: 2.447

Review 2.  Functional Microbiomics in Liver Transplantation: Identifying Novel Targets for Improving Allograft Outcomes.

Authors:  Michael Kriss; Elizabeth C Verna; Hugo R Rosen; Catherine A Lozupone
Journal:  Transplantation       Date:  2019-04       Impact factor: 4.939

Review 3.  Probiotics and liver disease.

Authors:  Vishal Sharma; Shashank Garg; Sourabh Aggarwal
Journal:  Perm J       Date:  2013

Review 4.  Gut microbiota and liver diseases.

Authors:  Masami Minemura; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

5.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

Review 6.  Gut microbiota and bacterial translocation in digestive surgery: the impact of probiotics.

Authors:  Shunichiro Komatsu; Yukihiro Yokoyama; Masato Nagino
Journal:  Langenbecks Arch Surg       Date:  2017-03-20       Impact factor: 3.445

Review 7.  Impact of environmental factors on alloimmunity and transplant fate.

Authors:  Leonardo V Riella; Jessamyn Bagley; John Iacomini; Maria-Luisa Alegre
Journal:  J Clin Invest       Date:  2017-05-08       Impact factor: 14.808

8.  Probiotics as a preventive strategy for surgical infection in colorectal cancer patients: a systematic review and meta-analysis of randomized trials.

Authors:  Priscilla Régia de Andrade Calaça; Raquel Pedrosa Bezerra; Wendell Wagner Campos Albuquerque; Ana Lúcia Figueiredo Porto; Maria Taciana Holanda Cavalcanti
Journal:  Transl Gastroenterol Hepatol       Date:  2017-08-23

Review 9.  Probiotics for people with hepatic encephalopathy.

Authors:  Rohan Dalal; Richard G McGee; Stephen M Riordan; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2017-02-23

Review 10.  Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics.

Authors:  Min Seok Cho; Sang Yeol Kim; Ki Tae Suk; Byung-Yong Kim
Journal:  J Microbiol       Date:  2018-10-25       Impact factor: 3.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.